China-based Hebron Technology Co Ltd, and Ukrainian firm Research and Product Complex BioPromin Ltd (BioPromin), are investing up to $50 million for a joint venture that will develop, manufacture, and market BioPromin’s proprietary noninvasive blood analyzer products in China.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
